Damdamon, Juvy -.
HRN: 24-58-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2024
CEFUROXIME 750MG (VIAL)
02/20/2024
02/27/2024
IV
750mg
Q8H
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes